DE60234951D1 - Adenosin a2a rezeptor antagonisten - Google Patents
Adenosin a2a rezeptor antagonistenInfo
- Publication number
- DE60234951D1 DE60234951D1 DE60234951T DE60234951T DE60234951D1 DE 60234951 D1 DE60234951 D1 DE 60234951D1 DE 60234951 T DE60234951 T DE 60234951T DE 60234951 T DE60234951 T DE 60234951T DE 60234951 D1 DE60234951 D1 DE 60234951D1
- Authority
- DE
- Germany
- Prior art keywords
- adenosine
- receptor antagonists
- antagonists
- receptor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US33434201P | 2001-11-30 | 2001-11-30 | |
PCT/US2002/037710 WO2003048165A1 (en) | 2001-11-30 | 2002-11-26 | ADENOSINE A2a RECEPTOR ANTAGONISTS |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60234951D1 true DE60234951D1 (de) | 2010-02-11 |
Family
ID=23306779
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60234951T Expired - Lifetime DE60234951D1 (de) | 2001-11-30 | 2002-11-26 | Adenosin a2a rezeptor antagonisten |
Country Status (19)
Country | Link |
---|---|
US (1) | US6916811B2 (de) |
EP (1) | EP1448565B1 (de) |
JP (2) | JP4284182B2 (de) |
KR (1) | KR20050044593A (de) |
CN (1) | CN1692116A (de) |
AR (1) | AR037680A1 (de) |
AT (1) | ATE453647T1 (de) |
AU (1) | AU2002346503A1 (de) |
CA (1) | CA2468649C (de) |
DE (1) | DE60234951D1 (de) |
ES (1) | ES2336435T3 (de) |
HK (1) | HK1063780A1 (de) |
HU (1) | HUP0402018A3 (de) |
IL (1) | IL161716A0 (de) |
MX (1) | MXPA04005209A (de) |
PE (1) | PE20030665A1 (de) |
TW (1) | TW200306837A (de) |
WO (1) | WO2003048165A1 (de) |
ZA (1) | ZA200404161B (de) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100384847C (zh) * | 2000-05-26 | 2008-04-30 | 先灵公司 | 腺苷A2a受体拮抗剂 |
US6964288B2 (en) * | 2001-07-06 | 2005-11-15 | Ksaria Corporation | Apparatus and method for automated preparation of an optical fiber |
CA2463598C (en) | 2001-10-15 | 2009-09-08 | Schering Corporation | Imidazo (4,3-e)-1,2,4-triazolo(1,5-c) pyrimidines as adenosine a2a receptor antagonists |
JP2005527635A (ja) * | 2002-05-30 | 2005-09-15 | キング・ファーマシューティカルズ・リサーチ・アンド・デベロプメント・インコーポレイティッド | 三環ピラゾロトリアゾロピリミジン環構造を有する薬学的に活性な化合物及び使用方法 |
ES2354875T3 (es) * | 2002-12-19 | 2011-03-18 | Schering Corporation | Uso de antagonistas del receptor a2a de la adenosina para el tratamiento o prevención del síndrome extrapiramidal. |
EP1678168B1 (de) * | 2003-10-24 | 2012-07-11 | Exelixis, Inc. | Modulatoren von p70s6-kinase und anwendungsverfahren |
ES2278353T3 (es) * | 2003-10-28 | 2007-08-01 | Schering Corporation | Procedimiento para preparar 5-amino-pirazolo-(4,3-e)-1,2,4-triazolo(1,5-c)pirimidinas sustituidas. |
KR20060111581A (ko) * | 2003-12-19 | 2006-10-27 | 쉐링 코포레이션 | 약제학적 조성물 |
ATE556712T1 (de) * | 2005-06-07 | 2012-05-15 | Kyowa Hakko Kirin Co Ltd | A2a antagonisten zur behandlung von motorischen störungen |
ES2273599B1 (es) | 2005-10-14 | 2008-06-01 | Universidad De Barcelona | Compuestos para el tratamiento de la fibrilacion auricular. |
PE20080145A1 (es) * | 2006-03-21 | 2008-02-11 | Janssen Pharmaceutica Nv | Tetrahidro-pirimidoazepinas como moduladores de trpv1 |
US7723343B2 (en) * | 2007-03-30 | 2010-05-25 | King Pharmaceuticals Research And Development, Inc. | Adenosine A2A receptor antagonists |
PE20091102A1 (es) | 2007-12-17 | 2009-07-25 | Janssen Pharmaceutica Nv | Moduladores imidazolo-, oxazolo-, y tiazolopirimidina del trpv1 |
US20100203165A1 (en) | 2008-08-01 | 2010-08-12 | Gerald Horn | Compositions and methods for treatment of disorders or conditions of the eye |
SI2320911T1 (sl) | 2008-08-01 | 2014-12-31 | Eye Therapies Llc | Vazokonstrikcijski sestavki in metode uporabe |
US8952011B2 (en) | 2008-08-01 | 2015-02-10 | Eye Therapies Llc | Compositions and methods for the treatment of nasal conditions |
CA2748174A1 (en) | 2008-12-30 | 2010-07-08 | Arqule, Inc. | Substituted 1h-pyrazolo[3,4-d]pyrimidine-6-amine compounds |
TW201100427A (en) | 2009-03-31 | 2011-01-01 | Arqule Inc | Substituted heterocyclic compounds |
US8987270B2 (en) | 2009-07-27 | 2015-03-24 | Eye Therapies Llc | Formulations of selective alpha-2 agonists and methods of use thereof |
US20110152271A1 (en) * | 2009-12-17 | 2011-06-23 | Gerald Horn | Compositions and methods for ophthalmic delivery of nasal decongestants |
US8445526B2 (en) | 2011-02-03 | 2013-05-21 | Glaucoma & Nasal Therapies Llc | Compositions and methods for treatment of glaucoma |
US8999938B2 (en) | 2013-06-21 | 2015-04-07 | Gnt Llc | Ophthalmic lipophilic drug delivery vehicle formulations |
CN110742893B (zh) * | 2018-07-23 | 2024-04-05 | 百济神州(北京)生物科技有限公司 | A2a受体拮抗剂治疗癌症的方法 |
MX2021006329A (es) | 2018-11-30 | 2021-08-11 | Merck Sharp & Dohme Llc | Derivados de amino triazolo quinazolina 9-sustituidos como antagonistas del receptor de adenosina, composiciones farmaceuticas y su uso. |
DE102019116986A1 (de) | 2019-06-24 | 2020-12-24 | Helmholtz-Zentrum Dresden-Rossendorf E. V. | Deuterierte 7-(3-(4-(2-([18F]Fluor)ethoxy)phenyl)propyl)-2-(furan-2-yl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amin-Derivate |
EP3999513A4 (de) * | 2019-07-17 | 2022-12-21 | Teon Therapeutics, Inc. | Adenosin-a2a-rezeptorantagonisten und verwendungen davon |
CN111825698B (zh) | 2019-07-30 | 2021-10-15 | 杭州阿诺生物医药科技有限公司 | 腺苷受体拮抗剂 |
CN112028891B (zh) | 2019-07-30 | 2022-07-05 | 厦门宝太生物科技股份有限公司 | 腺苷受体拮抗剂 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1264901B1 (it) | 1993-06-29 | 1996-10-17 | Schering Plough S P A | Analoghi eterociclici di 1,2,4-triazolo(15-c)pirimidine ad attivita' antagonista per il recettore a2 dell'adenosina |
US5565460A (en) * | 1993-07-27 | 1996-10-15 | Kyowa Hakko Koygo Co., Ltd. | Therapeutic purine agents for parkinson's disease |
IT1277392B1 (it) * | 1995-07-28 | 1997-11-10 | Schering Plough S P A | Analoghi eterociclici di 1,2,4-triazolo(1,5-c]pirimidine ad attivita' antagonista per il recettore a2a dell'adenosina |
IT1291372B1 (it) | 1997-05-21 | 1999-01-07 | Schering Plough S P A | Uso di analoghi eterociclici di 1,2,4-triazolo (1,5-c) pirimidine per la preparazione di medicamenti utili per il trattamento delle malattie |
US6921825B2 (en) * | 1998-09-16 | 2005-07-26 | King Pharmaceuticuals Research & Development, Inc. | Adenosine A3 receptor modulators |
US6448253B1 (en) * | 1998-09-16 | 2002-09-10 | King Pharmaceuticals Research And Development, Inc. | Adenosine A3 receptor modulators |
CN100384847C (zh) | 2000-05-26 | 2008-04-30 | 先灵公司 | 腺苷A2a受体拮抗剂 |
JP2005527635A (ja) * | 2002-05-30 | 2005-09-15 | キング・ファーマシューティカルズ・リサーチ・アンド・デベロプメント・インコーポレイティッド | 三環ピラゾロトリアゾロピリミジン環構造を有する薬学的に活性な化合物及び使用方法 |
ES2326270T3 (es) * | 2003-04-23 | 2009-10-06 | Schering Corporation | Antagonistas del receptor de la adenosina a2a 2-alquinil- y 2-alquenil-pirazolo-(4,3-e)-1,2,4-triazolo-(1,5-c)-pirimidina. |
-
2002
- 2002-11-26 KR KR1020047007876A patent/KR20050044593A/ko not_active Application Discontinuation
- 2002-11-26 MX MXPA04005209A patent/MXPA04005209A/es active IP Right Grant
- 2002-11-26 AU AU2002346503A patent/AU2002346503A1/en not_active Abandoned
- 2002-11-26 WO PCT/US2002/037710 patent/WO2003048165A1/en active Application Filing
- 2002-11-26 IL IL16171602A patent/IL161716A0/xx unknown
- 2002-11-26 CA CA002468649A patent/CA2468649C/en not_active Expired - Fee Related
- 2002-11-26 ES ES02784568T patent/ES2336435T3/es not_active Expired - Lifetime
- 2002-11-26 US US10/304,931 patent/US6916811B2/en not_active Expired - Lifetime
- 2002-11-26 EP EP02784568A patent/EP1448565B1/de not_active Expired - Lifetime
- 2002-11-26 DE DE60234951T patent/DE60234951D1/de not_active Expired - Lifetime
- 2002-11-26 AT AT02784568T patent/ATE453647T1/de not_active IP Right Cessation
- 2002-11-26 CN CNA02823782XA patent/CN1692116A/zh active Pending
- 2002-11-26 JP JP2003549355A patent/JP4284182B2/ja not_active Expired - Fee Related
- 2002-11-26 HU HU0402018A patent/HUP0402018A3/hu unknown
- 2002-11-27 TW TW091134471A patent/TW200306837A/zh unknown
- 2002-11-27 PE PE2002001143A patent/PE20030665A1/es not_active Application Discontinuation
- 2002-11-27 AR ARP020104561A patent/AR037680A1/es unknown
-
2004
- 2004-05-27 ZA ZA200404161A patent/ZA200404161B/en unknown
- 2004-08-28 HK HK04106478.4A patent/HK1063780A1/xx not_active IP Right Cessation
-
2008
- 2008-06-04 JP JP2008147306A patent/JP2008260776A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2005511699A (ja) | 2005-04-28 |
CN1692116A (zh) | 2005-11-02 |
ES2336435T3 (es) | 2010-04-13 |
PE20030665A1 (es) | 2003-08-08 |
ATE453647T1 (de) | 2010-01-15 |
US20030212059A1 (en) | 2003-11-13 |
HK1063780A1 (en) | 2005-01-14 |
AR037680A1 (es) | 2004-12-01 |
JP2008260776A (ja) | 2008-10-30 |
HUP0402018A3 (en) | 2008-06-30 |
EP1448565A1 (de) | 2004-08-25 |
CA2468649C (en) | 2009-03-10 |
KR20050044593A (ko) | 2005-05-12 |
WO2003048165A1 (en) | 2003-06-12 |
CA2468649A1 (en) | 2003-06-12 |
HUP0402018A2 (hu) | 2005-02-28 |
EP1448565B1 (de) | 2009-12-30 |
US6916811B2 (en) | 2005-07-12 |
AU2002346503A1 (en) | 2003-06-17 |
ZA200404161B (en) | 2005-11-30 |
TW200306837A (en) | 2003-12-01 |
JP4284182B2 (ja) | 2009-06-24 |
IL161716A0 (en) | 2004-09-27 |
MXPA04005209A (es) | 2004-08-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE293627T1 (de) | Adenosin a2a rezeptor antagonisten | |
DE60234951D1 (de) | Adenosin a2a rezeptor antagonisten | |
ATE317844T1 (de) | Adenosine a2a receptor antagonisten | |
DE60219196D1 (de) | BICYCLISCHE Ä1,2,4ö-TRIAZOL ADENOSIN A2a REZEPTOR ANTAGONISTEN | |
HUP0401925A3 (en) | A2b adenosine receptor antagonists | |
ATE256141T1 (de) | N-pyrazol a2a rezeptor agonisten | |
ATE240341T1 (de) | C-pyrazol a2a rezeptor agonisten | |
NO20032277L (no) | Aminotiazoler og deres anvendelse som adenosinreseptorantagonister | |
ATE461932T1 (de) | Pyrazoloä4,3-eü-1,2,4-triazoloä1,5-cüpyrimidine als antagonisten des adenosin-a2a-rezeptors | |
DK1446379T3 (da) | Arylanilin-beta2-adrenergiske receptoragonister | |
IL175759A0 (en) | A2b adenosine receptor antagonists | |
HUP0401437A3 (en) | Adenosine a3 receptor agonists | |
ATE432282T1 (de) | 2-alkinyl- und 2-alkenyl-pyrazolo-ä4,3-eü -1,2,4- triazolo-ä1,5-cü -pyrimidinadenosin a2a rezeptorantagonisten | |
NO20052866D0 (no) | Imidazokinolinderivater som adenosin A3 reseptorligander | |
DE60333866D1 (de) | 2-aminocarbonlyl-chinolin-verbindungen als adenosin diphosphat plättchenrezeptor antagonisten | |
NO20020979L (no) | Selektive A2B-adenosinreseptorantagonister | |
ATE394402T1 (de) | Kondensierte purinderivate als a1- adenosinrezeptorantagonisten | |
DE60214408D1 (de) | 5-METHOXY-8-ARYL-i1,2,4öTRIAZOLOi1,5-AöPYRIDINE DERIVATIVE ALS ADENOSIN-REZEPTOR ANTAGONISTEN | |
DE60106974D1 (de) | Aminotriazolopyridinderivate als adenosinrezeptorliganden | |
DE60220713D1 (de) | Ribofuranosyluronamid Derivate als Kristall; ein menschlicher Adenosin A2A Rezeptor Agonsit | |
SI1401837T1 (sl) | Purinski derivati kot antagonisti adenozinskega receptorja A2B |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |